JPS63122459A - Mesh for breast wall - Google Patents
Mesh for breast wallInfo
- Publication number
- JPS63122459A JPS63122459A JP61268902A JP26890286A JPS63122459A JP S63122459 A JPS63122459 A JP S63122459A JP 61268902 A JP61268902 A JP 61268902A JP 26890286 A JP26890286 A JP 26890286A JP S63122459 A JPS63122459 A JP S63122459A
- Authority
- JP
- Japan
- Prior art keywords
- mesh
- chest wall
- months
- acid
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000481 breast Anatomy 0.000 title 1
- 210000000779 thoracic wall Anatomy 0.000 claims description 21
- 229920000954 Polyglycolide Polymers 0.000 claims description 7
- 239000004633 polyglycolic acid Substances 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000002861 polymer material Substances 0.000 claims 1
- 239000002759 woven fabric Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000009940 knitting Methods 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002271 resection Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 206010072960 Chest wall tumour Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 208000002325 Funnel Chest Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 229920000339 Marlex Polymers 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 206010034204 Pectus excavatum Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000018223 neoplasm of chest wall Diseases 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 231100001063 rib abnormality Toxicity 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 231100001061 sternum abnormality Toxicity 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は外科手術において胸壁の欠損修復のために使用
されるメツシュの提供に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to the provision of a mesh for use in repairing defects in the chest wall during surgery.
(従来技術)
現在、臨床で広く用いられている胸壁補修用の補強材は
ポリプロピレン製のMarlex Mesh (C,R
。(Prior art) Currently, the reinforcing material for chest wall repair that is widely used in clinical practice is Marlex Mesh (C, R
.
Bard、Inc社製、商品名)がある。(manufactured by Bard, Inc., trade name).
しかしながら、かかる従来のものは強度的には充分その
機能を果し得るが体内吸収性でないため生体組織が侵入
して胸壁を再建した後にも異物として体内に残り、少な
からず組織反応を起しつづける欠点を有する。また、成
長期の子供に適用したとき、胸壁再建後に胸壁の成長を
阻害することが知られている。However, although these conventional devices are strong enough to perform their functions, they are not absorbable by the body, so even after the chest wall is reconstructed, living tissue invades and remains in the body as a foreign object, causing considerable tissue reactions. It has its drawbacks. It is also known to inhibit chest wall growth after chest wall reconstruction when applied to growing children.
(発明が解決しようとする問題点)
本発明はかかる点、生体内分解吸収性を特徴とする胸壁
メツシュを提供するもので、生体親和性に優れ、また、
機能を果したのち長く体内に残りつづけることがないた
め異物反応を起すことがなく、特に、成長期の子供への
適用において他に例をみない優れた効果を有するもので
ある。(Problems to be Solved by the Invention) The present invention provides a chest wall mesh that is biodegradable and absorbable, has excellent biocompatibility, and
Since it does not remain in the body for a long time after fulfilling its function, it does not cause a foreign body reaction, and it has an unparalleled excellent effect especially when applied to growing children.
(問題を解決するための手段)
しかるに、その構成において、生体吸収性の合成高分子
繊条により多孔状に編、織成されてなる生地をもって構
成されたことに特徴を有し、特に、その素材として生体
分解吸収性の高分子であるポリグリコール酸もしくはポ
リ乳酸もしくはこれらの共重合体で構成したことに特徴
を有するものである。(Means for Solving the Problem) However, its structure is characterized by the fact that it is composed of a fabric that is knitted and woven in a porous manner using bioabsorbable synthetic polymer fibers. It is characterized in that it is made of biodegradable and absorbable polymers such as polyglycolic acid or polylactic acid, or a copolymer thereof.
(作用)
本発明メツシュが好適に適用される胸部外科領域におけ
る外科治療の例としては次のようなものがある。(Function) Examples of surgical treatments in the thoracic surgery field to which the mesh of the present invention is suitably applied include the following.
即ち、胸壁の異常として肋骨や胸骨の異常、漏斗胸、鳩
胸、胸壁ヘルニアなどで先天性のもの。In other words, chest wall abnormalities include rib and sternum abnormalities, pectus excavatum, pigeon chest, and chest wall hernia, which are congenital.
或はこれらの後天性のもの、また、交通事故や労務上で
の事故で胸壁に重篤な損傷を起すもの0例えば、交通事
故などの外傷で同時に片側、あるいは両側胸郭の多数の
肋骨骨折を生じ胸郭のささえがなくなるため重篤な呼吸
循環障害をきたす動揺胸郭と呼ばれるもの、さらに胸壁
の炎症や胸壁の腫瘍、かかる炎症の場合は適切な化学療
法を行えばよいが難治のものは助軟骨切除や痩孔切除な
どを行う必要があり、また、腫瘍の場合も放射線療法を
行うこともよいが大部分の限局性胸壁腫瘍では外科的切
除を行うことが最もよい治療法とされ、これらのケース
では何れも外科的な手術が必要とされている。Or these acquired injuries, or those that cause serious damage to the chest wall due to a traffic accident or work-related accident. This is called a fluctuating thorax, which causes serious respiratory and circulation disorders due to the lack of support from the thorax, as well as inflammation of the chest wall and tumors of the chest wall.In the case of such inflammation, appropriate chemotherapy can be performed, but in cases that are difficult to treat, auxiliary cartilage is needed. It is necessary to perform excision or fistula resection, and radiation therapy may also be performed in the case of tumors, but surgical resection is considered the best treatment for most localized chest wall tumors; In all cases, surgical intervention is required.
かかる用途に適用されるメツシュは整形外科領域で用い
られる骨固定用器具はどの高い力学的強度は必要とされ
ず、組織が入り込んで切除した胸壁が再建されるまで足
がかりとなるだけでも意味があり、従って、2〜3力月
で分解吸収されるポリグリコール酸から18〜24力月
で分解吸収されるポリ−L−乳酸まで所望の使い分けが
可能である。The mesh used for this purpose does not require any high mechanical strength compared to the bone fixation devices used in the orthopedic field, and it is meaningful just to allow tissue to enter and serve as a stepping stone until the resected chest wall is reconstructed. Therefore, it is possible to use as desired, ranging from polyglycolic acid which is decomposed and absorbed in 2 to 3 months to poly-L-lactic acid which is decomposed and absorbed in 18 to 24 months.
また、その適用は欠損部の大きさに合せて切断されたメ
ツシュを胸腔側から縫いつけて適用するものであり、か
かる素材は機部を果した後、徐々に体内に吸収され異物
として長く体内に留まることがなく、小児への適用にお
いても胸部の成長を妨げることがないため極めて理想的
である。In addition, it is applied by sewing a mesh cut to the size of the defect from the thoracic cavity side, and after the material has been removed, it is gradually absorbed into the body and remains in the body as a foreign material for a long time. It is extremely ideal for use in children because it does not stay in place and does not hinder the growth of the chest.
以下、その構成及び適用効果等について例を挙げて説明
する。Hereinafter, its configuration, application effects, etc. will be explained by giving examples.
[製造例11
フェノール10に対しトリクロロフェノール7の割合で
混合した溶媒中にて溶解し、これを190℃で3分間加
熱した後30℃まで冷却して測定したときの粘度(ηs
p/c)が1.5であるポリグリコール酸チップを24
5℃で溶融紡糸し、延伸して6フイラメントで120デ
ニールの糸を得た。これを4本合糸してS撚を507/
Mかけた後、105℃にて3時間熱処理した。この約4
80デニールのポリグリコール酸系を用いて14ゲージ
のトリコット編とし、編密度288g/rn’の胸壁用
メツシュとした。[Production Example 11 Viscosity (ηs
24 polyglycolic acid chips with a p/c) of 1.5
It was melt spun at 5°C and drawn to obtain a 120 denier yarn with 6 filaments. Combine 4 of these yarns to make an S twist of 507/
After applying M, heat treatment was performed at 105° C. for 3 hours. This about 4
A 14-gauge tricot knit using 80 denier polyglycolic acid was used to make a chest wall mesh with a knitting density of 288 g/rn'.
このようにして得た胸壁用メツシュは適度の腰を有し、
以下のように優れた評価を得た。The chest wall mesh thus obtained has a moderate waist,
It received excellent evaluations as shown below.
[in vivo分解性評価1
前記の如く構成したメツシュをl cmX 5 cmの
大きさにカットし、家兎の皮下に埋入し、1週、2週、
2力月後に層殺し、材料の分解吸収速度、組織反応をポ
リプロピレン製の市販のマーレックスメツシュ(ソフト
)との比較において評価した。[In vivo degradability evaluation 1 The mesh constructed as described above was cut into a size of 1 cm x 5 cm, and implanted under the skin of a domestic rabbit for 1 week, 2 weeks,
After 2 months, the layer was removed, and the decomposition and absorption rate of the material and tissue reaction were evaluated in comparison with a commercially available Marex mesh (soft) made of polypropylene.
組織反応については2週間後マーレックスメツシュでは
毛細血管の侵入が見られたが1本例ではほとんどみられ
ず炎症反応の少ないことが認められた。2力月後には本
例のメツシュは溶けてなくなっていた。Regarding the tissue reaction, although capillary invasion was observed in the Marex mesh after 2 weeks, it was hardly observed in one case, indicating that there was little inflammatory reaction. After two months, the mesh in this case had melted and disappeared.
また1強力保持率は第1表に示す通り初期及び術後に必
要とされるに十分な強力を保持し、その後分解により急
激に低下した。In addition, as shown in Table 1, the 1-strength retention rate maintained sufficient strength to meet the initial and postoperative needs, but then rapidly decreased due to decomposition.
これに対し、従来品は一定して低い強力を維持した。In contrast, the conventional product maintained a consistently low strength.
第1表 (単位=Kgf)
[実用評価]
雑種成犬の右胸壁の肋骨を切断し、胸腔内側から前記に
より構成したメツシュを縫いつけた。Table 1 (Unit = Kgf) [Practical Evaluation] The ribs on the right chest wall of an adult mongrel dog were cut, and the mesh constructed as described above was sewn from the inside of the chest cavity.
この縫合部の状態を見るため術後3週間、lk月、2力
月、3力月目に実験犬を層殺し、縫合部の状態を観察し
た。3週間目ですでに組織が入り込んで切除した胸壁が
再建されていた。1力月後にはメツシュの目の形がまだ
見られるがメツシュそのものの強度はゼロに近い状薦で
あった。In order to observe the condition of the sutured area, the experimental dogs were sacrificed at 3 weeks, 1 month, 2 months, and 3 months after the operation, and the condition of the suture area was observed. By the third week, tissue had already entered and the chest wall that had been removed was being rebuilt. A month later, the shape of the eye of the mesh can still be seen, but the strength of the mesh itself was close to zero.
2力月後には胸壁はほとんど完全に近い状態で再建され
ていた。尚1分解過程における周囲への組織反応は少な
く3力月後には分解吸収されてメツシュの形は全くわか
らなくなっていた。Two months later, the battlements had been rebuilt in near-perfect condition. There was little tissue reaction to the surrounding tissue during the decomposition process, and after three months, the mesh had been decomposed and absorbed, and the shape of the mesh was no longer recognizable.
[製造例2]
分子1410000のポリ−L−乳酸チツブを230℃
で溶融紡糸し、延伸して6フイラメン)、120デニー
ルの糸を得た。これを4本合糸して50↑/MのS撚を
かけた後、105℃にて3時間熱処理した。[Production Example 2] Poly-L-lactic acid with a molecular weight of 1,410,000 was heated at 230°C.
The yarn was melt-spun and drawn (6 filaments) to obtain a 120-denier yarn. Four of these yarns were twisted, S-twisted at 50↑/M, and then heat treated at 105° C. for 3 hours.
この約480デニールのポリ−L−乳酸系を用いて10
ゲージのトリコット編とし、編密度200g/rr/の
胸壁用メツシュを得た。Using this approximately 480 denier poly-L-lactic acid system,
A mesh for battlements was obtained with a gauge tricot knitting and a knitting density of 200 g/rr/.
これを前記のin viマ0分解性評価と同じように1
cmX 5 cmの大きさにカットし、家兎の皮下に
埋入し、1力月、6力月、12カ月、24カ月後に層殺
し、材料の分解吸収速度、組織反応をみた。This was evaluated as 1 in the same way as the above in vitro degradability evaluation
It was cut to a size of cm x 5 cm and implanted subcutaneously in a domestic rabbit, and after 1 month, 6 months, 12 months, and 24 months, the layer was removed and the decomposition and absorption rate of the material and tissue reaction were observed.
その結果、1力月後に若干の血管新生が見られたが以後
は炎症反応も極めて少なく親和性は良好であった。As a result, some angiogenesis was observed after 1 month, but thereafter there was very little inflammatory reaction and the affinity was good.
また、その強力保持率は1力月、6力月、12力月後ニ
オイテ夫h 5.5Kgf 、4.8KgF 、3.3
Kgf、 1. IKgf 。In addition, its strong retention rate is 5.5Kgf, 4.8KgF, 3.3 after 1 month, 6 months, and 12 months.
Kgf, 1. IKgf.
であり、24力月後においてはOとなり1体内に分解吸
収されメツシュの形は全くわからなくなっていた。However, after 24 months, it became O and was decomposed and absorbed into one body, and the shape of the mesh was completely unknown.
(発明の効果)
本発明は以上のように従来にない優れた特徴を有し、胸
壁切除部の補綴用として極めて好適に適用可能なもので
ある。(Effects of the Invention) As described above, the present invention has excellent features not found in the prior art, and can be very suitably applied to prosthesis of a chest wall resection.
尚9例としてポリグリコール酸とポリ−し一乳酸を記述
したが、両者の共重合体によるメツシュも可能であり、
これらの組成や重合度、熱処理条件などにより分解性の
コントロールが可能なものである。Although polyglycolic acid and poly-monolactic acid are described as nine examples, meshes made of copolymers of both are also possible.
Degradability can be controlled by controlling these compositions, degree of polymerization, heat treatment conditions, etc.
また、その編織組織は特に限定はしないが、適用上密度
が200〜300g/ゴの範囲にあるのが好適であり、
これが200g/ m”未満であると強力的に不足し、
腰がないため適、当でなく、逆に300g/ m″を越
えると硬くなりすぎるため適用したとき患部に刺激を与
え好ましくない、また、その編織組織は切断端のほつれ
などが起らぬトリコット編が特に好ましい、また、ポリ
グリゴール酸とポリ−L−乳酸或いは1両者の共重合体
による交編織も勿論可能である。Further, the weaving structure is not particularly limited, but it is preferable for the density to be in the range of 200 to 300 g/g for the purpose of application.
If this is less than 200g/m", there is a strong shortage,
It is not suitable because it has no waist, and on the other hand, if it exceeds 300g/m, it becomes too hard and irritates the affected area when applied, which is undesirable.Also, the woven structure is a tricot that does not cause fraying at the cut ends. Knitting is particularly preferred, and interlacing knitting and weaving of polyglygolic acid, poly-L-lactic acid, or a copolymer of both is of course also possible.
本発明は以上のように従来にない優れた胸壁用メツシュ
である。As described above, the present invention is an excellent chest wall mesh that has never existed before.
Claims (1)
生地より成ることを特徴とする胸壁用メッシュ。 2、生体内分解吸収性の高分子がポリグリコール酸もし
くはポリ乳酸であることを特徴とする特許請求の範囲第
1項記載の胸壁用メッシュ。 3、生体内分解吸収性の高分子がポリグリコール酸とポ
リ乳酸の共重合体であることを特徴とする特許請求の範
囲第1項記載の胸壁用メュ。[Claims] 1. A chest wall mesh comprising a knitted or woven fabric made of biodegradable and absorbable polymer material. 2. The chest wall mesh according to claim 1, wherein the biodegradable and absorbable polymer is polyglycolic acid or polylactic acid. 3. The chest wall mesh according to claim 1, wherein the biodegradable and absorbable polymer is a copolymer of polyglycolic acid and polylactic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61268902A JPH0741063B2 (en) | 1986-11-11 | 1986-11-11 | Chest wall mesh |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61268902A JPH0741063B2 (en) | 1986-11-11 | 1986-11-11 | Chest wall mesh |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63122459A true JPS63122459A (en) | 1988-05-26 |
JPH0741063B2 JPH0741063B2 (en) | 1995-05-10 |
Family
ID=17464855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61268902A Expired - Lifetime JPH0741063B2 (en) | 1986-11-11 | 1986-11-11 | Chest wall mesh |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0741063B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294469A (en) * | 1992-06-17 | 1994-03-15 | Mitsui Toatsu Chemicals, Incorporated | Industrial woven fabric and composite sheet comprising same |
WO1995008354A1 (en) * | 1993-09-24 | 1995-03-30 | Takiron Co., Ltd. | Implantation material |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61181469A (en) * | 1985-02-07 | 1986-08-14 | グンゼ株式会社 | Breast support material |
-
1986
- 1986-11-11 JP JP61268902A patent/JPH0741063B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61181469A (en) * | 1985-02-07 | 1986-08-14 | グンゼ株式会社 | Breast support material |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294469A (en) * | 1992-06-17 | 1994-03-15 | Mitsui Toatsu Chemicals, Incorporated | Industrial woven fabric and composite sheet comprising same |
WO1995008354A1 (en) * | 1993-09-24 | 1995-03-30 | Takiron Co., Ltd. | Implantation material |
Also Published As
Publication number | Publication date |
---|---|
JPH0741063B2 (en) | 1995-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1646410B1 (en) | Synthetic, bioabsorbable polymer materials and implants | |
US10994057B2 (en) | Articles of poly(butylene succinate) and copolymers thereof | |
JP7235762B2 (en) | Medical device comprising poly(butylene succinate) and copolymers thereof | |
US3736646A (en) | Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures | |
EP0349505B1 (en) | A novel surgical material | |
JP2659424B2 (en) | Felt implant | |
JP5280839B2 (en) | Absorbable / biodegradable composite yarn and property-adjusting surgical implant formed therefrom | |
JP4522591B2 (en) | Braided surgical mesh | |
US3739773A (en) | Polyglycolic acid prosthetic devices | |
DK169400B1 (en) | Knitted surgical mask | |
JP2001025477A (en) | Surgical knitted mesh | |
US6773459B2 (en) | Medical, bioresorbable implant, process for its production and the use thereof | |
CA1247041A (en) | Modification of polyglycolic structural elements to achieve variable in-vivo physical properties | |
JP2011505220A (en) | Implants for parastomal hernia | |
CN105063875A (en) | Manufacturing method for knitted mesh of prosthetic device | |
JP2009039511A (en) | Mesh implant with interlocking knitted structure | |
JP2007525601A (en) | Polyhydroxyalkanoate medical fabric and medical fiber | |
JP2011505220A5 (en) | ||
EP3370640B1 (en) | Time dependent physiologic tissue scaffold | |
CN114630931A (en) | Medical devices comprising poly (butylene succinate) and copolymers thereof | |
CN107970493B (en) | Absorbable plugging device | |
EP0050215A1 (en) | Modification of polyglycolic acid to achieve variable in-vivo physical properties | |
Ikada | Bioabsorbable fibers for medical use | |
JP6502342B2 (en) | Absorbable poly (p-dioxanone-co-glycolide) monofilament fiber with post-implant medium-term strength maintenance | |
Kinoshita et al. | Study on the efficacy of biodegradable polyf (l-lactide) mesh for supporting transplanted particulate cancellous bone and marrow: experiment involving subcutaneous implantation in dogs |